BRCA1/BRCA2
BRCA1 and BRCA2 are tumor-suppressor genes, and inherited mutations in them markedly raise the lifetime risk of breast, ovarian, prostate, and pancreatic cancers. A preventive practice tests them once to inform personalized screening and risk-reduction decisions, ideally alongside genetic counseling.
What It Measures
Tumor suppressor gene mutations.
Optimal vs. Lab Range
Target range for optimal health and longevity based on research.
Population-based reference range from standard labs.
Why It Matters
Markedly elevated breast/ovarian/prostate/pancreatic cancer risk.
When Low
—
When Optimal
Negative → population baseline risk.
When High
Pathogenic → high-risk screening and counseling.
How to Optimize
Genetic counseling; high-risk surveillance protocol.
Key Interventions & Linked Compounds
Strong (10/10)Key Interventions
Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.
Ordering Notes
Specimen
Buccal swab or whole blood (EDTA)
Patient prep
No fasting required. Maintain usual diet and medications unless advised.
Recommended cadence
Re-test every 3–6 months when actively optimizing; annually for monitoring.
Reporting unit
variant
Pre-analytic notes
Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.
Recommended Follow-Up Actions
- 1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift BRCA1/BRCA2.
- 2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
- 3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
- 4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
- 5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.
Quick Actions
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation